Abigail Culshaw

Abigail Culshaw is a highly experienced professional in the field of immunology, currently serving as a Director at Autolus Therapeutics since January 2018, where previous roles included Associate Director, Principal Scientist, and Senior Scientist. Prior to this tenure, Abigail was a Research Associate at Imperial College London from February 2012 to December 2017, contributing to research on T cells in the context of dengue and zika virus infections under Professor Gavin Screaton. Abigail earned a Doctor of Philosophy (Ph.D.) in Immunology from the University of Oxford in 2011 and a Bachelor of Science (BSc) in Immunology from The University of Edinburgh in 2007.